It is tempting to speculate that despite the genetic and biological heterogeneity, some common cancer-associated changes in the lysosomal compartment that normally promote growth, invasiveness and drug resistance might also sensitize cells to LMP and subsequent LCD induced by lysosome-targeting strategies (38). Here, PDLIM7 is linked to cancer.